Demonstrating robust effects in vitro, these inhibitors also enhanced hematopoiesis and erythropoiesis in immunodeficient NPSG and NCG-X mice and various anemia models,21 including the Rpl11 haploinsufficiency mouse model of DBA. The gene discussed is RPL11; the disease is anemia.